SECURE Webinar 18: Blueprints to Breakthroughs: Enhancing Vaccine Manufacturing Ecosystems in DMCs

Series: ADB's SECURE Webinar Series

SECURE Webinar 18: Blueprints to Breakthroughs: Enhancing Vaccine Manufacturing Ecosystems in DMCs

24 October 2024

The SECURE Webinar 18 is a collaboration with ADB’s Human and Social Development Office’s Solutions Development Working Group on Health Systems Strengthening (HSD-SDWG HSS), focusing on vaccine manufacturing and regulatory ecosystems. 

This 90-minute virtual event spotlighted ADB's initiatives to advance domestic vaccine production, regulatory oversight, and clinical trials in DMCs, particularly in Bangladesh, Indonesia, Pakistan, the Philippines, and Viet Nam. Through case studies, participants gained insights into ADB's collaborative efforts to enhance vaccine access and market stability, addressing each country's unique challenges. The webinar explored regulatory capacity building, domestic vaccine production, international partnerships, and technology transfers to support long-term health security.

SECURE Webinar 18 allowed participants to learn from successful projects and exchange ideas on building robust vaccine production and regulatory frameworks with regional experts. This session was ideal for professionals engaged in public health, government policy, and development work who are interested in understanding how strategic investments and partnerships could strengthen health security in the Asia-Pacific region.

Program and Learning Materials: 
Date Session / Activity Presentation Material Speaker(s)
24 Oct 2024 Welcome and Introductions Moderator: Brian Riley
24 Oct 2024 Enhancing Vaccine Manufacturing Ecosystems in ADB Developing Member Countries
This presentation gives an overview of how to enhance vaccine manufacturing ecosystems in ADB Developing Member Countries, with a focus on addressing ...
Eduardo Banzon
24 Oct 2024 Presentations ADB's Initiatives to Support Vaccine Manufacturing
This presentation gives an overview of ADB's initiatives to support vaccine manufacturing and regulatory strengthening in the Asia and the Pacific region...
Dinesh Arora
24 Oct 2024 Presentations Strengthening Domestic Vaccine Development and Manufacturing in Viet Nam as part of Post-COVID-19 Health Security Response
This presentation gives an overview of strengthening domestic vaccine development and manufacturing in Viet Nam as part of the post-COVID-19 health security...
Aman Singh, Do Tuan Dat
24 Oct 2024 Presentations Regulatory Systems Strengthening in the Western Pacific Region
This presentation gives an overview of the regulatory systems strengthening in the Western Pacific Region, focusing on the role and functions of National...
Jinho Shin
24 Oct 2024 Landscape Assessment and Policy Recommendations: Scaling Nucleic Acid-based Biopharmaceutical Technologies in Asia and the Pacific
This presentation gives an overview of the landscape assessment and policy recommendations for scaling nucleic acid-based biopharmaceutical technologies...
Ragini Ahluwalia, Varun Srivastava
24 Oct 2024 Panel discussion ADB’s Role in Vaccine Ecosystem Development and Regulatory Strengthening Nilgun Aydogan

Benjamin Coghlan

Varun Srivastava
24 Oct 2024 Open Forum/Q&A Moderator: Brian Riley
24 Oct 2024 Concluding Remarks Alexo Esperato

Disclaimer

The views expressed on this website are those of the authors and do not necessarily reflect the views and policies of the Asian Development Bank (ADB) or its Board of Governors or the governments they represent. ADB does not guarantee the accuracy of the data included in this publication and accepts no responsibility for any consequence of their use. By making any designation of or reference to a particular territory or geographic area, or by using the term “country” in this document, ADB does not intend to make any judgments as to the legal or other status of any territory or area.